Showing 1,401 - 1,420 results of 2,564 for search '(( significant decrease decrease ) OR ( significant ((non decrease) OR (a decrease)) ))~', query time: 0.57s Refine Results
  1. 1401

    Table 1_Correlation between CBC-derived inflammatory indicators and all-cause mortality with rheumatoid arthritis: a population-based study.docx by Yu Liu (6938)

    Published 2025
    “…The Kaplan-Meier analysis indicated a significant decrease in the survival probability among individuals with elevated SIRI, NLR, and MLR levels. …”
  2. 1402

    Data Sheet 1_Knowledge, attitude, and practice toward foodborne disease among Chinese college students: a cross-sectional survey.pdf by Xingming Ma (446316)

    Published 2024
    “…In particular, there was a notable decrease in practice scores toward foodborne diseases among male students, ethnic minority students, and non-medical students. …”
  3. 1403

    Table 1_Mitochondrial oxygen metabolism as a potential predictor of weight loss after laparoscopic sleeve gastrectomy for class III obesity.xlsx by Markus Engelmann (20516393)

    Published 2025
    “…We compared the values obtained in patients with obesity with those of age- and sex-matched healthy controls and investigated changes up to one year after LSG. 48 patients (46.5 years [35.5-55.3]; 38/48 female (79.2%); BMI 46.7 [42.5-51.0]) completed the study. They showed a significant weight loss and a decrease in relative fat mass after six months. …”
  4. 1404

    DataSheet2_Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.docx by Jung Hoon Cha (19723588)

    Published 2024
    “…</p>Conclusions<p>Our study underscores the pivotal role of CHIT1 in MASH. The observed significant improvement in inflammation and hepatic fibrosis, particularly at higher doses of the CHIT1 inhibitor, strongly suggests the potential of CHIT1 as a therapeutic target in MASH accompanied by progressive liver fibrosis.…”
  5. 1405

    DataSheet1_Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.zip by Jung Hoon Cha (19723588)

    Published 2024
    “…</p>Conclusions<p>Our study underscores the pivotal role of CHIT1 in MASH. The observed significant improvement in inflammation and hepatic fibrosis, particularly at higher doses of the CHIT1 inhibitor, strongly suggests the potential of CHIT1 as a therapeutic target in MASH accompanied by progressive liver fibrosis.…”
  6. 1406

    A Proposal for Implementation of Multi-Factor Authentication (MFA) System for Enhanced Security By Stephen Mikah Makoshi by Stephen Mikah Makoshi (20998469)

    Published 2025
    “…</p><p dir="ltr">· <b>Regulatory Non-Compliance</b>: A breach due to compromised passwords can lead to legal consequences.…”
  7. 1407

    Table 1_The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases.docx by Wenxin Mu (9911610)

    Published 2024
    “…Significance<p>Burning mouth syndrome (BMS) is a chronic orofacial pain disorder that seriously affects quality of life of patients. …”
  8. 1408

    Image 1_The immediate pain relief of low-level laser therapy for burning mouth syndrome: a retrospective study of 94 cases.tif by Wenxin Mu (9911610)

    Published 2024
    “…Significance<p>Burning mouth syndrome (BMS) is a chronic orofacial pain disorder that seriously affects quality of life of patients. …”
  9. 1409

    Image 1_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.pdf by Yi-Chang Zhao (14080107)

    Published 2025
    “…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”
  10. 1410

    Image 2_Practical utility of meropenem therapeutic drug monitoring: a systematic review of evidence for clinical application.pdf by Yi-Chang Zhao (14080107)

    Published 2025
    “…Adverse reactions showed a non-significant reduction (RR = 0.65; 95% CI: 0.38–1.11). …”
  11. 1411

    Table 1_Association between serum albumin and severe impairment of activities of daily living in patients with stroke: a cross-sectional study.docx by Ranran Bi (20505614)

    Published 2025
    “…After adjusting for confounding factors, the multivariate analysis revealed a 7% decrease in severe impairment of ADL after stroke for every unit (g/L) increase in serum albumin levels. …”
  12. 1412

    Table 1_Molecular epidemiological characteristics of pertussis in a pediatric hospital in Jinan City, China, 2022 to 2024.docx by Miao Liu (148274)

    Published 2025
    “…Annual BP positivity rates showed a significant increase from 2022 to 2024 (14.56, 3.26, and 32.24%, respectively; χ<sup>2</sup> = 2698.353, p < 0.001). …”
  13. 1413

    Supplementary Material for: A comparative cross-sectional study of hair density, hair shaft diameter of different severities of anterior scalp marginal traction alopecia in women. by Anaba E.L. (16407435)

    Published 2024
    “…With increasing severity of AMTA, there was a significant decrease in HD: Grade 1 had HD of 227.56/cm2 compared to 131.22/cm2 in grade 4 at the intertemporal area, p<0.001. …”
  14. 1414

    Supplementary file 1_Characteristics, clinical evidence and implementation effects of conditional approvals for drugs in China, a pooled analysis from 2020 to 2023.docx by Li Yang (6520)

    Published 2025
    “…CAs have been shown to decrease the development time, review time, and drug lag period, notably compared to non-CAs, and differences exist in the development time, review time, and drug lag period among CAs. …”
  15. 1415

    Supplementary file 1_Catalpol—a compound from Rehmannia glutinosa can improve hyperlipidemia by modulating gut microbiota and endogenous metabolic pathways.zip by Xinfeng Pei (22597664)

    Published 2025
    “…The 16S rRNA sequencing results showed that the consumption of an HFD led to a significant increase in the abundance of Firmicutes and a decrease in that of Bacteroidetes. …”
  16. 1416

    Table1_Surviving septic patients endotyped with a functional assay demonstrate active immune responses.docx by Adam D. Price (19842741)

    Published 2024
    “…‘Immunocompetent’ endotype patients on day 1 had a higher proportion of favorable to non-favorable discharges compared to the ‘immunosuppressed’ endotype. …”
  17. 1417

    Image2_Surviving septic patients endotyped with a functional assay demonstrate active immune responses.jpeg by Adam D. Price (19842741)

    Published 2024
    “…‘Immunocompetent’ endotype patients on day 1 had a higher proportion of favorable to non-favorable discharges compared to the ‘immunosuppressed’ endotype. …”
  18. 1418

    Image3_Surviving septic patients endotyped with a functional assay demonstrate active immune responses.jpeg by Adam D. Price (19842741)

    Published 2024
    “…‘Immunocompetent’ endotype patients on day 1 had a higher proportion of favorable to non-favorable discharges compared to the ‘immunosuppressed’ endotype. …”
  19. 1419

    Image1_Surviving septic patients endotyped with a functional assay demonstrate active immune responses.jpeg by Adam D. Price (19842741)

    Published 2024
    “…‘Immunocompetent’ endotype patients on day 1 had a higher proportion of favorable to non-favorable discharges compared to the ‘immunosuppressed’ endotype. …”
  20. 1420

    DataSheet1_Hepatic and pulmonary macrophage activity in a mucosal challenge model of Ebola virus disease.zip by Timothy G. Wanninger (20296455)

    Published 2024
    “…</p>Results<p>Hepatic macrophages in the EBOV-infected group demonstrated a mixed inflammatory/non-inflammatory profile, with upregulation of CD163 protein expression, associated with macrophage activation syndrome. …”